MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Parkinson's disease (G20)

HealthDay 08 July at 02.58 PM

Structure, Function of Brain Connectome Tied to Gray Matter Atrophy in Parkinson Disease

For patients with mild Parkinson disease (PD), the structural and functional architecture of the brain connectome is associated with progression of gray matter (GM) atrophy, according to a study published online June 25 in Radiology.Silvia Basaia, Ph.D., from IRCCS San Raffaele Scientific Institute in Milan, and colleagues examined the s

HealthDay 05 July at 02.37 PM

Acupuncture Aids Sleep in Patients With Parkinson Disease

Acupuncture is associated with improved sleep quality in patients with Parkinson disease, according to a study published online June 26 in JAMA Network Open.Mingyue Yan, Ph.D., from the First Clinical College of Guangzhou University of Chinese Medicine in China, and colleagues randomly assigned 78 patients with Parkinson disease and

HealthDay 24 June at 03.14 PM

Smartwatch, Smartphone Can Assess Parkinson Disease Progression

Gait and tremor measures derived from a commercially available smartwatch and smartphone could help evaluate the efficacy of therapies for Parkinson disease (PD), according to a study published online June 12 in npj: Parkinson's Disease.Jamie L. Adams, M.D., from the University of Rochester Medical Center in New York, and colleagues exa

Evalytics 15 April at 05.39 PM

Parkinson's Disease: New theory on the disease's origins and spread

The article suggests Parkinson's disease may stem from environmental toxins inhaled into the brain's smell center or ingested through the gut. It emphasizes the importance of understanding and preventing exposure to such toxins to combat not only Parkinson's but also other brain disorders like ALS and Alzheimer's.

Evalytics 19 March at 06.25 AM

Scientists take on 'moonshot' project mapping the human brain in hopes of fighting disease

The Allen Institute, founded by Paul Allen in 2003, embarked on an ambitious mission to map the 86 billion neurons of the human brain. This endeavor aims to decode the intricate workings of the brain and provide insights into various neurological diseases.

Evalytics 04 March at 06.32 PM

High-intensity exercise can reverse neurodegeneration in Parkinson's, study suggests

High-intensity exercise may reverse Parkinson's neurodegeneration, preserving dopamine neurons, with brain imaging showing improved health after six months. It's crucial for managing Parkinson's, potentially offering neuroprotective benefits beyond medication, but more research is needed for a full understanding.

Evalytics 14 February at 07.19 PM

Researchers 3D-print functional human brain tissue

UW-Madison scientists created 3D-printed brain tissue mimicking normal function, aiding research on disorders like Alzheimer's. They horizontally layered neurons in a soft gel, enabling communication and network formation resembling human brains, offering a precise and accessible technique for studying brain conditions and drug testing.

Evalytics 06 February at 06.40 AM

Pickleball Boom Nets New Healthcare Opportunities

Pickleball's escalating popularity comes with a steep rise in injuries, estimated to cost the US medical system a substantial $377 million in 2023 alone. This surge in injuries, however, is being viewed as an opportunity by some healthcare providers. Rather than just reacting to the problem, they are forging partnerships with pickleball organizations to proactively address injury prevention and ca

Evalytics 05 February at 08.18 PM

Behind Elon Musk’s brain chip: Decades of research and lofty ambitions to meld minds with computers

The article discusses Neuralink, a company founded by Elon Musk, and explores the science behind it. It covers Neuralink's brain-machine interface technology and its potential applications in medical and human enhancement fields. It also touches upon the challenges and ethical considerations associated with this emerging technology.

HealthDay 22 January at 04.44 PM

QOL Outcomes Stable With Neurostimulation in Parkinson Disease

For patients with Parkinson disease (PD), differences in quality of life (QOL) outcomes are seen with deep brain stimulation of the subthalamic nucleus (STN-DBS), according to a study published online Jan. 18 in JAMA Network Open.Stefanie T. Jost, Ph.D., from the University of Cologne in Germany, and colleagues examined the long-term ef

HealthDay 15 November at 04.53 PM

Cardiac 18F-Dopamine PET Can Predict Lewy Body Diseases

Cardiac 18F-dopamine positron emission tomography (PET) can identify at-risk individuals who are subsequently diagnosed with a central Lewy body disease (LBD), according to a study published online Oct. 26 in the Journal of Clinical Investigation.David S. Goldstein, M.D., Ph.D., from the National Institutes of Health in Be

Evalytics 31 October at 04.27 PM

EPA proposes to ban all uses of cancer-causing contaminant TCE

The US EPA has proposed a ban on trichloroethylene (TCE), a cancer-causing chemical used in manufacturing. This move aims to address health concerns linked to TCE exposure, including liver damage and Parkinson's disease. The ban would be phased in over time, starting with consumer products within a year.